Navigation Links
XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System
Date:5/25/2011

ATLANTA, May 25, 2011 /PRNewswire/ -- XDATA retains Adapt IP Ventures to market XDATA's intellectual property including patents and fully-functioning prototype focused on breast cancer detection. Over many decades, XDATA has developed, patented and tested methods and devices for automatically capturing and combining ultrasound and X-ray mammography images. As validation of the value of XDATA's patents, leading companies and research hospitals including GE, Hologic, U-Systems and The General Hospital Corporation have cited these patents in their own inventions.

"We are very excited about our partnership with XDATA," comments Adapt IP Ventures' CEO Grant Moss. "With over 180,000 new cases of breast cancer that are diagnosed each year, resulting in 40,000 or more deaths, there is an urgent and immediate need in the industry for a more effective screening tool."

"XDATA's pioneering combination of 3-D ultrasound and traditional mammography is clinically proven to offer improved sensitivity in screening even the most challenging and early cancers. Automatically capturing these images reduces impact on both doctor's time and unit cost," states John Brownlee, Evince's President and Founder and technical advisor to Adapt IP Ventures. "We have worked with many image technologies, but few are truly saving thousands of lives simultaneously with precious health care dollars. XDATA's patented solution is precisely that unique combination."

"Adapt IP Ventures and Evince will play a critical role in getting our patented technology out to the market," said Kris Dines, Ph.D., President and Founder of XDATA. "We look forward to broad industry adoption of our technology through the channels of a market leading company."

For more information, contact Grant Moss at grant@adaptipventures.com, +1-770-353-0756.

About XDATA Corporation

XDATA Corporation (www.xdatarnd.com), based in Indianapolis, IN, is a research and development company focused on medical imaging for women's health.

About Adapt IP Ventures, LLC

Adapt IP Ventures (www.adaptipventures.com), based in Atlanta, GA, provides strategic advisory services designed to assist innovative firms understand and extract value from their intellectual property. By serving as a patent broker for its clients, Adapt IP Ventures develops custom strategies to sell, license or value patents.

About Evince Corporation

Evince(tm) of Tucson, AZ is a technology strategy and patent advisory firm with broad expertise, and acted as exclusive advisor on over $1B of technology transactions in the past 5 years.


'/>"/>
SOURCE Adapt IP Ventures, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
2. Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand
3. CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
4. Solos Endoscopy, Inc. Retains Expert Resource to Meet Requirements for ISO 13485 Quality Management System Initiative
5. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
6. China Pharma Holdings, Inc. Retains CCG Investor Relations
7. Connectyx Retains Services of CP Capital Securities as It Expands Its Presence in the $5 Billion US Electronic Health Record Market
8. Anadys Retains Lazard as Strategic Advisor
9. Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel
10. Independent Committee of Caraco Board Retains Independent Advisors for Consideration of Sun Pharma Proposal to Purchase Outstanding Shares and Caraco Acknowledges Filing of Purported Class Action Lawsuits
11. Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... with Gattefossé, the leader in innovative excipients and drug delivery solutions to health ...
Breaking Medicine News(10 mins):